179 related articles for article (PubMed ID: 8505104)
1. Sodium and angiotensin in hypertension induced by long-term nitric oxide blockade.
Jover B; Herizi A; Ventre F; Dupont M; Mimran A
Hypertension; 1993 Jun; 21(6 Pt 2):944-8. PubMed ID: 8505104
[TBL] [Abstract][Full Text] [Related]
2. [Sodium intake and angiotensin in hypertension induced by chronic NO synthase inhibition in the rat].
Jover B; Nafrialdi ; Herizi A; Mimran A
Arch Mal Coeur Vaiss; 1993 Aug; 86(8):1197-9. PubMed ID: 7510468
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide and the depressor response to angiotensin blockade in hypertension.
Guan H; Cachofeiro V; Pucci ML; Kaminski PM; Wolin MS; Nasjletti A
Hypertension; 1996 Jan; 27(1):19-24. PubMed ID: 8591882
[TBL] [Abstract][Full Text] [Related]
4. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis].
Gouédard O; Gaudet E; Blanc J; Ponchon P; Elghozi JL
Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1013-7. PubMed ID: 8949370
[TBL] [Abstract][Full Text] [Related]
5. Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension.
Ribeiro MO; Antunes E; de Nucci G; Lovisolo SM; Zatz R
Hypertension; 1992 Sep; 20(3):298-303. PubMed ID: 1516948
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II and alpha 1-adrenergic tone in chronic nitric oxide blockade-induced hypertension.
Qiu C; Engels K; Baylis C
Am J Physiol; 1994 May; 266(5 Pt 2):R1470-6. PubMed ID: 8203622
[TBL] [Abstract][Full Text] [Related]
7. Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system.
Zanchi A; Schaad NC; Osterheld MC; Grouzmann E; Nussberger J; Brunner HR; Waeber B
Am J Physiol; 1995 Jun; 268(6 Pt 2):H2267-73. PubMed ID: 7541960
[TBL] [Abstract][Full Text] [Related]
8. Endogenous vasoactive systems and the pressor effect of acute N omega-nitro-L-arginine methyl ester administration.
Nafrialdi N; Jover B; Mimran A
J Cardiovasc Pharmacol; 1994 May; 23(5):765-71. PubMed ID: 7521459
[TBL] [Abstract][Full Text] [Related]
9. Sympathetic functions in NG-nitro-L-arginine-methyl-ester-induced hypertension: modulation by the renin-angiotensin system.
K-Laflamme A; Foucart S; Moreau P; Lambert C; Cardinal R; de Champlain J
J Hypertens; 1998 Jan; 16(1):63-76. PubMed ID: 9533419
[TBL] [Abstract][Full Text] [Related]
10. Contribution of the renin-angiotensin system to short-term blood pressure variability during blockade of nitric oxide synthesis in the rat.
Gouédard O; Blanc J; Gaudet E; Ponchon P; Elghozi JL
Br J Pharmacol; 1996 Nov; 119(6):1085-92. PubMed ID: 8937709
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II: nitric oxide interaction and the distribution of blood flow.
Sigmon DH; Beierwaltes WH
Am J Physiol; 1993 Dec; 265(6 Pt 2):R1276-83. PubMed ID: 8285267
[TBL] [Abstract][Full Text] [Related]
12. Renin-angiotensin system in the pressor effect of acute N-omega-nitro-L-arginine methyl ester.
Nafrialdi ; Jover B; Mimran A
J Hypertens Suppl; 1993 Dec; 11(5):S324-5. PubMed ID: 8158406
[No Abstract] [Full Text] [Related]
13. Role of NO and angiotensin II in the early development of endothelial functions impairment and cardiac hypertrophy in deoxycorticosterone acetate-salt hypertension.
K-Laflamme A; Oster L; Cardinal R; de Champlain J
Can J Physiol Pharmacol; 1998 Jun; 76(6):665-75. PubMed ID: 9923405
[TBL] [Abstract][Full Text] [Related]
14. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats.
Siragy HM; Carey RM
J Clin Invest; 1997 Jul; 100(2):264-9. PubMed ID: 9218502
[TBL] [Abstract][Full Text] [Related]
15. Control of blood pressure and end-organ damage in maturing salt-loaded stroke-prone spontaneously hypertensive rats by oral angiotensin II receptor blockade.
Camargo MJ; von Lutterotti N; Campbell WG; Pecker MS; James GD; Timmermans PB; Laragh JH
J Hypertens; 1993 Jan; 11(1):31-40. PubMed ID: 8382237
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension.
Nakamoto H; Ferrario CM; Fuller SB; Robaczewski DL; Winicov E; Dean RH
Hypertension; 1995 Apr; 25(4 Pt 2):796-802. PubMed ID: 7536715
[TBL] [Abstract][Full Text] [Related]
17. Renal effects of acute endothelial-derived relaxing factor blockade are not mediated by angiotensin II.
Baylis C; Engels K; Samsell L; Harton P
Am J Physiol; 1993 Jan; 264(1 Pt 2):F74-8. PubMed ID: 8430832
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of hypertension and renal injury by salt-loading during chronic nitric oxide inhibition. Effects of TCV-116, a novel angiotensin II receptor antagonist.
Okamura M; Konishi Y; Nishimura M; Umetani N; Iwai J; Negoro N; Inoue T; Takeda T; Kanayama Y
Blood Press Suppl; 1994; 5():75-8. PubMed ID: 7889207
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II subtype AT1 receptor blockade prevents hypertension and renal insufficiency induced by chronic NO-synthase inhibition in rats.
Hropot M; Langer KH; Wiemer G; Grötsch H; Linz W
Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):312-7. PubMed ID: 12644905
[TBL] [Abstract][Full Text] [Related]
20. Interaction of nitric oxide and the renin angiotensin system in renal hypertensive rats.
Lee BH; Shin HS
Jpn J Pharmacol; 1997 May; 74(1):83-90. PubMed ID: 9195301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
